More bad news came in 2025. UnitedHealth Group reported lower-than-expected first-quarter earnings in April. The company ...

This fast growth has created some high expectations for Hims & Hers stock. It now has a price-to-earnings ratio (P/E) of 79, ...

Diabetes care startup Omada Health went public Friday 14 years after its founding. Here's what its major investors' stakes ...

In the last week, the United States market has been flat, yet it has experienced an 11% increase over the past year with earnings forecasted to grow by 14% annually. In this environment, dividend ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

UnitedHealthcare sued The Guardian on Wednesday for defamation, claiming the British daily ran information it knew to be ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

Equity award would come only if chief executive stays three years; one advisory service questioned the grant, saying it ...

Markets ended lower on Tuesday, weighed down by IT, financials, and other rate-sensitive stocks. Investor sentiment remained ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth, America's largest health insurance provider, is trading at its lowest valuation in over a decade. Check out why ...